GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » EBITDA Margin %

Biovica International AB (OSTO:BIOVIC B) EBITDA Margin % : -764.75% (As of Apr. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biovica International AB's EBITDA for the three months ended in Apr. 2025 was kr-17.83 Mil. Biovica International AB's Revenue for the three months ended in Apr. 2025 was kr2.33 Mil. Therefore, Biovica International AB's EBITDA margin for the quarter that ended in Apr. 2025 was -764.75%.


Biovica International AB EBITDA Margin % Historical Data

The historical data trend for Biovica International AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EBITDA Margin % Chart

Biovica International AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,597.69 -2,614.87 -3,019.65 -1,569.52 -892.32

Biovica International AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,022.06 -1,224.45 -787.76 -888.50 -764.75

Competitive Comparison of Biovica International AB's EBITDA Margin %

For the Biotechnology subindustry, Biovica International AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's EBITDA Margin % falls into.


;
;

Biovica International AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biovica International AB's EBITDA Margin % for the fiscal year that ended in Apr. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Apr. 2025 )/Revenue (A: Apr. 2025 )
=-76.918/8.62
=-892.32 %

Biovica International AB's EBITDA Margin % for the quarter that ended in Apr. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=-17.834/2.332
=-764.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Biovica International AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines